Anika Therapeutics Stock Price on March 13, 2024
| ANIK Stock | USD 25.97 0.40 1.56% |
Below is the normalized historical share price chart for Anika Therapeutics extending back to May 03, 1993. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Anika Therapeutics stands at 25.97, as last reported on the 30th of April, with the highest price reaching 26.10 and the lowest price hitting 25.55 during the day.
If you're considering investing in Anika Stock, it is important to understand the factors that can impact its price. We consider Anika Therapeutics very steady. Anika Therapeutics secures Sharpe Ratio (or Efficiency) of 0.1, which signifies that the company had a 0.1% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Anika Therapeutics, which you can use to evaluate the volatility of the firm. Please confirm Anika Therapeutics' Risk Adjusted Performance of 0.0624, downside deviation of 1.76, and Mean Deviation of 1.46 to double-check if the risk estimate we provide is consistent with the expected return of 0.17%.
Capital Stock is expected to rise to about 158.6 K this year, although the value of Total Stockholder Equity will most likely fall to about 120.9 M. . At this time, Anika Therapeutics' Price To Sales Ratio is quite stable compared to the past year. Price Book Value Ratio is expected to rise to 1.73 this year, although the value of Price To Operating Cash Flows Ratio is projected to rise to (176.45). Anika Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 29th of April 1993 | 200 Day MA 22.1128 | 50 Day MA 25.4366 | Beta 0.751 |
Anika |
Sharpe Ratio = 0.1021
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ANIK | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 1.71 actual daily | 15 85% of assets are more volatile |
Expected Return
| 0.17 actual daily | 3 97% of assets have higher returns |
Risk-Adjusted Return
| 0.1 actual daily | 7 93% of assets perform better |
Based on monthly moving average Anika Therapeutics is performing at about 7% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Anika Therapeutics by adding it to a well-diversified portfolio.
Price Book 1.749 | Enterprise Value Ebitda (29.15) | Price Sales 2.2275 | Shares Float 10.7 M | Wall Street Target Price 30.33 |
Anika Therapeutics Main Headline on 13th of March 2024
Anika Therapeutics Non-GAAP EPS of 0.05 beats by 0.28, reven... by seekingalpha.com
Anika Therapeutics beats earnings estimates in Q4 2023, with revenue exceeding expectations.
Anika Therapeutics Valuation on March 13, 2024
It is possible to determine the worth of Anika Therapeutics on a given historical date. On March 13, 2024 Anika was worth 25.75 at the beginning of the trading date compared to the closed value of 25.4. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Anika Therapeutics stock. Still, in general, we apply an absolute valuation method to find Anika Therapeutics' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Anika Therapeutics where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Anika Therapeutics' related companies.
| Open | High | Low | Close | Volume | |
| 26.20 | 26.29 | 25.45 | 25.79 | 91,850 | |
03/13/2024 | 25.75 | 26.14 | 25.40 | 25.40 | 133,730 |
| 23.87 | 26.08 | 21.00 | 24.54 | 212,908 |
| Backtest Anika Therapeutics | | | Anika Therapeutics History | | | Anika Therapeutics Valuation | Previous | Next |
Anika Therapeutics Trading Date Momentum on March 13, 2024
| On March 14 2024 Anika Therapeutics was traded for 24.54 at the closing time. The top price for the day was 26.08 and the lowest listed price was 21.00 . The trading volume for the day was 212.9 K. The trading history from March 14, 2024 was a factor to the next trading day price decrease. The overall trading delta against the next closing price was 3.39% . The overall trading delta against the current closing price is 0.28% . |
Anika Therapeutics Fundamentals Correlations and Trends
By evaluating Anika Therapeutics' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Anika Therapeutics' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Anika financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Anika Therapeutics Stock history
Anika Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Anika is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Anika Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Anika Therapeutics stock prices may prove useful in developing a viable investing in Anika Therapeutics
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 14.7 M | 12.7 M | |
| Net Loss | -17.1 M | -16.2 M |
Anika Therapeutics Quarterly Net Working Capital |
|
Anika Therapeutics Stock Technical Analysis
Anika Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Anika Therapeutics Period Price Range
Low | March 13, 2024
| High |
25.75 | 25.40 |
Anika Therapeutics April 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Anika Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Anika Therapeutics shares will generate the highest return on investment. By undertsting and applying Anika Therapeutics stock market strength indicators, traders can identify Anika Therapeutics entry and exit signals to maximize returns
Anika Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Anika Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Anika Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Anika to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.0624 | |||
| Jensen Alpha | 0.0788 | |||
| Total Risk Alpha | (0.08) | |||
| Sortino Ratio | 0.0434 | |||
| Treynor Ratio | 0.1605 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Anika Therapeutics. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy Anika Stock please use our How to buy in Anika Stock guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Anika Stock analysis
When running Anika Therapeutics' price analysis, check to measure Anika Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Anika Therapeutics is operating at the current time. Most of Anika Therapeutics' value examination focuses on studying past and present price action to predict the probability of Anika Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Anika Therapeutics' price. Additionally, you may evaluate how the addition of Anika Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Anika Therapeutics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Anika Therapeutics. If investors know Anika will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Anika Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.51) | Earnings Share (5.64) | Revenue Per Share 11.372 | Quarterly Revenue Growth 0.085 | Return On Assets (0.02) |
The market value of Anika Therapeutics is measured differently than its book value, which is the value of Anika that is recorded on the company's balance sheet. Investors also form their own opinion of Anika Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Anika Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Anika Therapeutics' market value can be influenced by many factors that don't directly affect Anika Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Anika Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Anika Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Anika Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.